BREAKING: First RSV vaccine gets FDA approval
The FDA on Wednesday approved the world’s first vaccine against the respiratory virus RSV: a single shot for adults ages 60 and up, made by pharmaceutical company GSK.
In a clinical trial, the single-dose shot lowered the risk of symptomatic illness by 83% and of severe illness by 94%.
Do something positive.